Windlas Biotech Ltd.

NSE: WINDLAS | BSE: 543329 | ISIN: INE0H5O01029 | Industry: Pharmaceuticals
| Mid-range Performer
1084.1000 16.60 (1.56%)
NSE Apr 17, 2025 15:31 PM
Volume: 177.1K
 

1084.10
1.56%
ICICI Securities Limited
Leading player in fast growing CDMO market With increasing globalisation and focus of large pharmaceutical players on cutting costs and optimising operations, CDMOs have seen significant acceptance in the pharmaceutical industry internationally over the last few years. The domestic formulations CDMO market has grown at a higher rate of ~13% compared to ~8.6% growth of the domestic formulations market (in terms of consumption) in the past five years. The company believe this increasing use of outsourcing by pharmaceutical companies for launch of...
Windlas Biotech Ltd. has gained 20.16% in the last 1 Month
More from Windlas Biotech Ltd.
Recommended